INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript
Operator: Greetings and welcome to the INmune Bio First Quarter 2024 Earnings Call. At the end of the presentation, there will be a question-and-answer session.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Rhenman & Partners Asset Management Henrik Rhenman | 178,284 | $2,094,837 | 0.19% | |
2. | Millennium Management Israel Englander | 159,192 | $1,870,506 | +558% | 0% |
3. | GLG Partners Noam Gottesman | 40,549 | $476,451 | +160% | 0% |
4. | Marshall Wace LLP Paul Marshall And Ian Wace | 26,825 | $315,194 | 0% | |
5. | 21,400 | $251,450 | +144% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$8.32 | 18,028 | Large Shareholder, Officer | 1,268,179 | 2024-04-19 | Filing | |
$8.32 | 18,028 | Large Shareholder, Officer, Director | 1,538,726 | 2024-04-19 | Filing | |
$8.32 | 14,423 | Large Shareholder, Officer | 1,510,806 | 2024-04-19 | Filing | |
$8.32 | 29,603 | Director | 66,603 | 2024-04-19 | Filing | |
$6.95 | 7,000 | Director | 37,000 | 2023-11-10 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$11.01 | 10,000 | Director | 82,187 | 2023-07-12 | Filing | |
$20.00 | 701 | Large Shareholder, Officer | 1,472,793 | 2021-11-03 | Filing | |
$20.00 | 1,025 | Large Shareholder, Officer | 1,219,158 | 2021-11-03 | Filing | |
$20.00 | 3,626 | Large Shareholder, Officer, Director | 1,490,674 | 2021-11-03 | Filing | |
$20.00 | 6,517 | Large Shareholder, Officer, Director | 1,494,300 | 2021-10-27 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 541,329 | $6,095,364 | 0% | |
2. | 257,929 | $2,904,282 | 0% | |
3. | 170,040 | $1,914,965 | 0% | |
4. | 109,848 | $1,236,888 | 0% | |
5. | 98,012 | $1,103,615 | 0.01% |